COMP <GO>
SBC vs UNH // FREE CASH FLOW YIELD
SBC Medical Group Holdings Incorporated (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: SBC 7
— UNH 6
▲ FREE CASH FLOW YIELD LEADER: UNH
LAST: $5.28 (-7.29%) • MKT CAP: $585.2M
fcf-yield
3.98%
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
fcf-yield
6.48%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SBC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.30% | 88.57% | -15.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.10% | 11.47% | +51.63 | SBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 16.4x | -10.35 | SBC | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 3.98% | 6.48% | -2.50 | UNH | /fcf-yield <GO> |
| Operating Margin | 38.90% | 4.82% | +34.08 | SBC | /operating-margins <GO> |
| Net Profit Margin | 29.40% | 3.14% | +26.26 | SBC | /net-margins <GO> |
| Revenue Growth (YoY) | -15.50% | 6.46% | -21.96 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.46 | 3.12 | +2.34 | SBC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.6 | 59.2 | +0.40 | SBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.7x | 17.7x | -7.04 | SBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $585.2M | $368.83B | -$368.25B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SBC REV | UNH REV | SBC GROSS % | UNH GROSS % | SBC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $173.6M | $447.57B | 73.3% | 88.7% | $23.3M | $16.07B |
| FY 2024 | $205.4M | $400.28B | 76.0% | 88.3% | $18.0M | $20.70B |
| FY 2023 | $193.5M | $371.62B | — | 89.6% | $50.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBC // BETA —
UNH // BETA 0.33